BAT8008 for Injection Clinical Trials

1 actively recruiting trial

Also known as: Recombinant humanized anti Trop2 monoclonal antibody for injection Exetecan conjugate

Pipeline

Phase 1: 1

Top Sponsors

Bio-Thera Solutions1

Indications

Advanced Solid Tumors1
Cancer1

Other1 trial

Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.